0001645113-20-000140.txt : 20200921
0001645113-20-000140.hdr.sgml : 20200921
20200921161608
ACCESSION NUMBER: 0001645113-20-000140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200918
FILED AS OF DATE: 20200921
DATE AS OF CHANGE: 20200921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GROENHUYSEN WILHELMUS CM
CENTRAL INDEX KEY: 0001264783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 201186478
MAIL ADDRESS:
STREET 1: C/O NAVTEQ CORPORATION
STREET 2: 222 MERCHANDISE MART STE 900
CITY: CHICAGO
STATE: IL
ZIP: 60654
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_160071932127330.xml
FORM 4
X0306
4
2020-09-18
0
0001645113
NovoCure Ltd
NVCR
0001264783
GROENHUYSEN WILHELMUS CM
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Ordinary Shares
2020-09-18
4
M
0
8262
7.48
A
150869
D
Ordinary Shares
2020-09-18
4
S
0
200
106.915
D
150669
D
Ordinary Shares
2020-09-18
4
S
0
2513
108.494
D
148156
D
Ordinary Shares
2020-09-18
4
S
0
3536
109.226
D
144620
D
Ordinary Shares
2020-09-18
4
S
0
1813
110.24
D
142807
D
Ordinary Shares
2020-09-18
4
S
0
200
110.885
D
142607
D
Options to Buy Ordinary Shares
7.48
2020-09-18
4
M
0
8262
0
D
2024-02-25
Ordinary Shares
8262.0
0
D
On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 200 shares in multiple trades at prices ranging from $106.74 to $107.09. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,513 shares in multiple trades at prices ranging from $107.84 to $108.83. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 3,536 shares in multiple trades at prices ranging from $108.84 to $109.82. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,813 shares in multiple trades at prices ranging from $109.84 to $110.66. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 200 shares in multiple trades at prices ranging from $110.85 to $110.92. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.
By: /s/ Steven Robbins, Attorney in Fact for Wilhelmus CM Groenhuysen
2020-09-21